Kiniksa Pharmaceuticals L...
(KNSA)
undefined
undefined%
At close: undefined
20.20
-0.30%
After-hours Dec 13, 2024, 04:00 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
PE Ratio | 21.81 | 1.42 | -1.28 | -1.69 | -0.92 | -2.01 | -2.44 | -6.59 |
PS Ratio | 1.14 | 1.18 | 5.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio | 0.70 | -0.53 | -0.30 | -0.53 | -0.42 | -1.07 | -1.76 | -6.14 |
P/FCF Ratio | 23.32 | 45.57 | -1.38 | -2.00 | -0.92 | -2.40 | -3.14 | -7.23 |
P/OCF Ratio | 23.10 | 44.75 | -1.60 | -2.00 | -0.94 | -2.56 | -3.15 | -7.23 |
OCF/S Ratio | 0.01 | 0.01 | -0.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / Equity Ratio | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio | 0.96 | 1.18 | 1.08 | 2.62 | 2.17 | 1.84 | 0.68 | 6.12 |
Current Ratio | 1.08 | 1.29 | 1.10 | 2.62 | 2.17 | 1.84 | 0.68 | 6.12 |
Asset Turnover | 0.51 | 0.48 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage | 0.00 | 1.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Return on Equity (ROE) | 3.21% | -37.27% | 23.38% | 31.19% | 45.46% | 53.15% | 72.32% | 93.16% |
Return on Assets (ROA) | 2.68% | 39.89% | -67.84% | -46.18% | -63.59% | -32.06% | -136.60% | -42.45% |
Return on Capital (ROIC) | -5.45% | 1.79% | -83.33% | -49.54% | -74.97% | -38.71% | -217.55% | -44.31% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 19.77% | 19.67% | 19.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Net Profit Margin | 1.30% | 20.82% | -102.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |